The MERS-coronavirus in the Netherlands As of 13 May 2014, RIVM and Erasmus MC have diagnosed the MERS coronavirus in two Dutch people. The patients are related and were infected during a joint journey to Saudi Arabia.
RIVM investigates dangers of e-cigarette At the request of State Secretary Martin van Rijn (VWS), RIVM is carrying out an investigation into the safety of e-cigarettes.
RIVM film about nanomaterials RIVM contributes to the safe use of nanomaterials through research, alerts and policy consultations, and this work is demonstrated in a short informative film.
No more complementary vaccinations against measles for children aged six months The measles epidemic, the first case of which occurred in the Netherlands in May 2013, is coming to an end.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
Nanotechnology in the fight against cancer Nanotechnology offers improved options for the diagnosis and treatment of cancer.
Further research into hazards posed by e-cigarettes Safety of nicotine-containing electronic cigarettes (e-cigarettes) cannot be confirmed because of the limited amount of published research in this area.
Teenage girl dies after measles infection Last weekend, a 17-year-old girl from the province of Zeeland (The Netherlands) has died of complications after a measles infection. She was not vaccinated against the disease.
Signs of MERS coronavirus found in dromedary camels Researchers searching for signs of Middle East respiratory syndrome coronavirus (MERS-CoV) in different livestock animals have found antibodies specific to the new virus in dromedary camels.
Extra measles vaccinations for risk groups Some areas of the Netherlands where families for religious reasons chose not to get their babies vaccinated are now reporting cases of measles, and it is expected that the number of cases will incr